Commentary: Vasopressin-induced hyponatremia in infants <3 months of age in the neonatal intensive care unit
A. Hebert, D. R. Rios, P. J. McNamara · 2025
Read Commentary: Vasopressin-induced hyponatremia in infants <3 months of age in the neonatal intensive care unit by A. Hebert, D. R. Rios, P. J. McNamara (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11788387.txt.
Description
Hebert, Rios, and McNamara comment on vasopressin-linked low sodium in young infants. Their 2025 commentary discusses a study of babies in intensive care. Vasopressin can support blood pressure and heart function in sick newborns. It can also drive sodium levels down in the blood. The original study mapped that side effect in infants under three months.
The commentators praise the work while urging balance. Low sodium can harm the brain if severe and sudden. Seizures and swelling are among the feared outcomes. Yet vasopressin's benefits for lung circulation may be life saving. End effects of mild sodium drops remain unknown, they note. Careful monitoring, not blanket avoidance, is their advice. Dosing judgment must weigh both sides per baby.
Catalog record
| CREATOR | A. Hebert, D. R. Rios, P. J. McNamara |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |